JP2022185110A5 - - Google Patents

Download PDF

Info

Publication number
JP2022185110A5
JP2022185110A5 JP2022163367A JP2022163367A JP2022185110A5 JP 2022185110 A5 JP2022185110 A5 JP 2022185110A5 JP 2022163367 A JP2022163367 A JP 2022163367A JP 2022163367 A JP2022163367 A JP 2022163367A JP 2022185110 A5 JP2022185110 A5 JP 2022185110A5
Authority
JP
Japan
Prior art keywords
methyl
compound according
alkyl
composition
cancer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2022163367A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022185110A (ja
Filing date
Publication date
Priority claimed from JP2019531992A external-priority patent/JP7158383B2/ja
Application filed filed Critical
Publication of JP2022185110A publication Critical patent/JP2022185110A/ja
Publication of JP2022185110A5 publication Critical patent/JP2022185110A5/ja
Pending legal-status Critical Current

Links

JP2022163367A 2016-12-15 2022-10-11 C-kit阻害剤としてのベンズイミダゾール化合物 Pending JP2022185110A (ja)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201662434839P 2016-12-15 2016-12-15
US62/434,839 2016-12-15
JP2019531992A JP7158383B2 (ja) 2016-12-15 2017-12-14 C-kit阻害剤としてのベンズイミダゾール化合物
PCT/US2017/066299 WO2018112140A1 (en) 2016-12-15 2017-12-14 Benzimidazole compounds as c-kit inhibitors

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2019531992A Division JP7158383B2 (ja) 2016-12-15 2017-12-14 C-kit阻害剤としてのベンズイミダゾール化合物

Publications (2)

Publication Number Publication Date
JP2022185110A JP2022185110A (ja) 2022-12-13
JP2022185110A5 true JP2022185110A5 (cg-RX-API-DMAC10.html) 2023-03-22

Family

ID=60888754

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2019531992A Expired - Fee Related JP7158383B2 (ja) 2016-12-15 2017-12-14 C-kit阻害剤としてのベンズイミダゾール化合物
JP2022163367A Pending JP2022185110A (ja) 2016-12-15 2022-10-11 C-kit阻害剤としてのベンズイミダゾール化合物

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2019531992A Expired - Fee Related JP7158383B2 (ja) 2016-12-15 2017-12-14 C-kit阻害剤としてのベンズイミダゾール化合物

Country Status (13)

Country Link
US (2) US11117883B2 (cg-RX-API-DMAC10.html)
EP (1) EP3555066A1 (cg-RX-API-DMAC10.html)
JP (2) JP7158383B2 (cg-RX-API-DMAC10.html)
KR (1) KR20190092538A (cg-RX-API-DMAC10.html)
CN (3) CN116283910A (cg-RX-API-DMAC10.html)
AU (3) AU2017376629B2 (cg-RX-API-DMAC10.html)
BR (1) BR112019012224A2 (cg-RX-API-DMAC10.html)
CA (1) CA3047107A1 (cg-RX-API-DMAC10.html)
EA (1) EA201991197A1 (cg-RX-API-DMAC10.html)
IL (3) IL287517B2 (cg-RX-API-DMAC10.html)
MA (1) MA53150A (cg-RX-API-DMAC10.html)
MX (2) MX390348B (cg-RX-API-DMAC10.html)
WO (1) WO2018112140A1 (cg-RX-API-DMAC10.html)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11117883B2 (en) * 2016-12-15 2021-09-14 Ariad Pharmaceuticals, Inc. Benzimidazole compounds as c-Kit inhibitors
CN109320503B (zh) * 2018-12-10 2022-07-01 怀化学院 苯并咪唑炔胺类化合物的无金属一锅合成方法
CA3129665A1 (en) 2019-03-21 2020-09-24 Onxeo A dbait molecule in combination with kinase inhibitor for the treatment of cancer
KR20220098759A (ko) 2019-11-08 2022-07-12 인쎄름 (엥스띠뛰 나씨오날 드 라 쌍떼 에 드 라 흐쉐르슈 메디깔) 키나제 억제제에 대해 내성을 획득한 암의 치료 방법
CN115362003B (zh) 2019-12-24 2024-03-22 卡尔那生物科学株式会社 二酰基甘油激酶调节化合物
WO2021148581A1 (en) 2020-01-22 2021-07-29 Onxeo Novel dbait molecule and its use
TWI890283B (zh) 2020-02-14 2025-07-11 美商基利科學股份有限公司 結合ccr8之抗體及融合蛋白及其用途
JP7651018B2 (ja) 2021-06-23 2025-03-25 ギリアード サイエンシーズ, インコーポレイテッド ジアシルグリセロールキナーゼ調節化合物
EP4359413A1 (en) 2021-06-23 2024-05-01 Gilead Sciences, Inc. Diacylglyercol kinase modulating compounds
MX2023014762A (es) 2021-06-23 2024-01-15 Gilead Sciences Inc Compuestos moduladores de diacilglicerol quinasa.
CN117355531A (zh) 2021-06-23 2024-01-05 吉利德科学公司 二酰基甘油激酶调节化合物
EP4423078A1 (en) 2021-10-28 2024-09-04 Gilead Sciences, Inc. Pyridizin-3(2h)-one derivatives
PE20241186A1 (es) 2021-10-29 2024-06-03 Gilead Sciences Inc Compuestos de cd73
US20240124412A1 (en) 2021-12-22 2024-04-18 Gilead Sciences, Inc. Ikaros zinc finger family degraders and uses thereof
CN118488948A (zh) 2021-12-22 2024-08-13 吉利德科学公司 Ikaros锌指家族降解剂及其用途
CA3248911A1 (en) 2022-01-28 2023-08-03 Gilead Sciences, Inc. POLY(ADENOSINE DIPHOSPHATE-RIBOSE) POLYMERASE 7 INHIBITORS
PL4245756T3 (pl) 2022-03-17 2025-02-17 Gilead Sciences, Inc. Środki degradujące palec cynkowy z rodziny ikaros i ich zastosowania
EP4511127A1 (en) 2022-04-21 2025-02-26 Gilead Sciences, Inc. Kras g12d modulating compounds
WO2024006929A1 (en) 2022-07-01 2024-01-04 Gilead Sciences, Inc. Cd73 compounds
EP4638436A1 (en) 2022-12-22 2025-10-29 Gilead Sciences, Inc. Prmt5 inhibitors and uses thereof
WO2024215754A1 (en) 2023-04-11 2024-10-17 Gilead Sciences, Inc. Kras modulating compounds
PE20260121A1 (es) 2023-04-21 2026-01-16 Gilead Sciences Inc Inhibidores de prmt5 y usos de los mismos
JP2026522894A (ja) 2023-06-30 2026-07-09 ギリアード サイエンシーズ, インコーポレイテッド Kras調節化合物
CN121568935A (zh) 2023-07-26 2026-02-24 吉利德科学公司 Parp7抑制剂
AU2024297978A1 (en) 2023-07-26 2026-02-05 Gilead Sciences, Inc. Parp7 inhibitors
US20250109147A1 (en) 2023-09-08 2025-04-03 Gilead Sciences, Inc. Kras g12d modulating compounds
EP4774280A1 (en) 2023-09-08 2026-07-15 Gilead Sciences, Inc. Kras g12d modulating compounds
WO2025096589A1 (en) 2023-11-03 2025-05-08 Gilead Sciences, Inc. Prmt5 inhibitors and uses thereof
US20250230168A1 (en) 2023-12-22 2025-07-17 Gilead Sciences, Inc. Azaspiro wrn inhibitors
WO2025245003A1 (en) 2024-05-21 2025-11-27 Gilead Sciences, Inc. Prmt5 inhibitors and uses thereof
US20260098049A1 (en) 2024-08-12 2026-04-09 Gilead Sciences, Inc. Kras modulating compounds
US20260130893A1 (en) 2024-10-21 2026-05-14 Gilead Sciences, Inc. Prmt5 inhibitors and uses thereof
WO2026136515A1 (en) 2024-12-19 2026-06-25 Gilead Sciences, Inc. Parp7 inhibitors

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5262564A (en) 1992-10-30 1993-11-16 Octamer, Inc. Sulfinic acid adducts of organo nitroso compounds useful as retroviral inactivating agents anti-retroviral agents and anti-tumor agents
BRPI0413746A (pt) * 2003-08-21 2006-10-24 Osi Pharm Inc composto ou um seu n-óxido ou seu sal farmaceuticamente aceitável, composição, e, método de tratamento de distúrbio hiperproliferativo
CA2589770A1 (en) * 2004-12-01 2006-06-08 Osi Pharmaceuticals, Inc. N-substituted benzimidazolyl c-kit inhibitors and combinatorial benzimidazole library
ES2360608T3 (es) * 2005-08-30 2011-06-07 Novartis Ag Bencimidazoles sustituidos y procedimientos de preparación.
PH12012500809A1 (en) * 2009-10-30 2012-11-26 Ariad Pharma Inc Methods and compositions for treating cancer
CA2780892C (en) * 2009-11-13 2017-02-14 Genosco Kinase inhibitors
EA201391485A1 (ru) * 2011-04-07 2014-03-31 Ариад Фармасьютикалз, Инк. Способы и композиции для лечения нейродегенеративных заболеваний
CN103664787B (zh) * 2012-09-17 2015-09-09 南京圣和药业股份有限公司 炔杂芳环化合物及其应用
CA2815506C (en) * 2012-12-12 2018-12-11 Ariad Pharmaceuticals, Inc. Crystalline forms of 3-(imidazo[1,2-b]pyridazin-3-ylethynyl)-4-methyl-n-{4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl}benzamide mono hydrochloride
GB2522226A (en) * 2014-01-17 2015-07-22 Agency Science Tech & Res Heteroaryl alkyne derivatives and uses thereof
US11117883B2 (en) * 2016-12-15 2021-09-14 Ariad Pharmaceuticals, Inc. Benzimidazole compounds as c-Kit inhibitors

Similar Documents

Publication Publication Date Title
JP2022185107A5 (cg-RX-API-DMAC10.html)
JP2020503299A5 (cg-RX-API-DMAC10.html)
CN115803325B (zh) 一种egfr抑制剂及其制备方法和应用
JP2020503297A5 (cg-RX-API-DMAC10.html)
JP7076453B2 (ja) 2-ベンゾピラジニル-n-ヘテロアリール-2-フェニル-アセトアミド化合物
JP2022520448A5 (cg-RX-API-DMAC10.html)
JP2020033357A5 (cg-RX-API-DMAC10.html)
KR102487451B1 (ko) Egfr 돌연변이 키나아제 활성을 조절하기 위한 화합물 및 조성물
CN103508961B (zh) 抗肿瘤药物
RU2378267C2 (ru) Новые пиримидинамидные производные и их применение
JP4653954B2 (ja) N−フェニル−2−ピリミジン−アミン誘導体
JP2022520811A5 (cg-RX-API-DMAC10.html)
JP2023536164A5 (cg-RX-API-DMAC10.html)
CN111247152B (zh) 作为激酶抑制剂的环状亚氨基嘧啶衍生物
CA2927079C (en) Salt of nitrogen-containing heterocyclic compound or crystal thereof, pharmaceutical composition, and flt3 inhibitor
BR112017006713B1 (pt) Inibidores de egfr, seus usos e seu processo de preparação, e composição farmacêutica
JP2017525757A5 (cg-RX-API-DMAC10.html)
JP2022526266A5 (cg-RX-API-DMAC10.html)
EP2054405A1 (en) Novel biaryl benzoimidazole derivatives and pharmaceutical composition comprising the same
CN104039798A (zh) 具有蛋白激酶抑制活性的噻吩并[3,2-d]嘧啶衍生物
BR112012011287B1 (pt) Compostos inibidores de cinase derivados de pirolopirimidina, sua formulação farmacêutica e seus usos
KR20130010895A (ko) 옥사디아졸 화합물, 그의 제조방법 및 용도
RU2018130703A (ru) Новое соединение 2,3,5-замещенного тиофена в качестве ингибитора протеинкиназы
AU2019217094B2 (en) Compounds for inhibiting TNIK and medical uses thereof
JP2017519818A5 (cg-RX-API-DMAC10.html)